Results 81 to 90 of about 371,957 (300)

Viral veterinary vaccines.

open access: yesDevelopments in biological standardization, 1999
The value of animal models for assessing the quality of veterinary viral vaccines is not to be despised, particularly since one has access to target animal models which are often more relevant than those in the laboratory, especially for challenge/protection studies. Immune protection involves complex immunological phenomena and processes.
Pastoret, Paul-Pierre, Falize, F.
openaire   +2 more sources

Viral Infection‐Inspired Autonomous Detection of Fusion‐Competent Viruses for Screening and Environmental Surveillance

open access: yesAdvanced Materials, EarlyView.
Inspired by viral entry mechanisms, the FUSION assay enables autonomous detection of respiratory viruses via membrane fusion–triggered CRISPR‐Cas13a activation. VEACON selectively fuses with fusion‐competent viruses, triggering fluorescence within confined vesicles.
Jae Chul Park   +15 more
wiley   +1 more source

Responsiveness to basement membrane extract as a possible trait for tumorigenicity characterization

open access: yesVaccine: X, 2019
Immortalized cell lines used to produce vaccines are expected to be described in terms of their tumorigenicity. However, current in vivo tumorigenicity assays can be time-consuming and results can be equivocal, especially for weakly tumorigenic cells ...
Haruhiko Murata   +7 more
doaj   +1 more source

Pre‐Encoded IFN‐I Sensitivity Exacerbates Memory T Cell Senescence in Solid Tumors

open access: yesAdvanced Science, EarlyView.
Type I interferon (IFN‐I) signaling promotes p21‐dependent cell cycle arrest in senescent tumor‐specific memory T cells, resulting in poor proliferative responses and solid tumor regression during cancer vaccination. Conversely, IFNα/β receptor blockade reinvigorates T cell proliferation to regress solid tumors and is more effective with increasing ...
Andrew Nguyen   +4 more
wiley   +1 more source

Vaccine Epidemiology and Decision-Making: A Bryant Student Focus [PDF]

open access: yes, 2018
The Centers for Disease Control and Prevention estimate that influenza has resulted in between 9.2 and 35.6 million illnesses and between 12,000 and 56,000 deaths annually since 2010 (1).
Coburn, Hannah
core   +1 more source

Treatment of Marburg and Ebola hemorrhagic fevers: A strategy for testing new drugs and vaccines under outbreak conditions. [PDF]

open access: yes, 2008
The filoviruses, Marburg and Ebola, have the dubious distinction of being associated with some of the highest case-fatality rates of any known infectious disease-approaching 90% in many outbreaks.
A.G. Sprecher   +105 more
core   +2 more sources

Viral Vaccine Strategies

open access: yesJournal of Biotechnology Research Center, 2022
Background: Lately, many viruses emerged or re-emerged from the obscurity and became considerable threats to the global health, raising alarms concerning their constant epidemic transmissions. A very important public health concern of those viruses is the continuous circulation amongst the population of the immunologically naive, susceptible hosts ...
openaire   +2 more sources

RNF213 Is an Interferon‐Stimulated Gene That Targets Influenza A Virus NP and Activates MDA5 to Restrict Infection

open access: yesAdvanced Science, EarlyView.
RNF213 is characterized as a dual‐functional antiviral effector. It directly mediates the degradation of the influenza A virus nucleoprotein (NP) while simultaneously activating the MDA5‐mediated innate immune signaling pathway. This coordinated response establishes a powerful host defense system against viral infection. ABSTRACT Influenza A virus (IAV)
Haoning Li   +5 more
wiley   +1 more source

Optimal Vaccine Allocation to Control Epidemic Outbreaks in Arbitrary Networks

open access: yes, 2013
We consider the problem of controlling the propagation of an epidemic outbreak in an arbitrary contact network by distributing vaccination resources throughout the network.
Enyioha, Chinwendu   +4 more
core   +1 more source

Molecular aspects of MERS-CoV [PDF]

open access: yes, 2017
This article is made available for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source.
Al-Ahmed, Shamsah H.   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy